cyclosporine and Arthritis, Psoriatic

cyclosporine has been researched along with Arthritis, Psoriatic in 80 studies

Research

Studies (80)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	26 (32.50)	18.2507
2000's	29 (36.25)	29.6817
2010's	22 (27.50)	24.3611
2020's	3 (3.75)	2.80

Authors

Authors	Studies
Furue, M; Harada, K; Hashimoto, A; Hatano, Y; Higashi, Y; Ikeda, K; Imafuku, S; Ito, K; Kaneko, S; Katayama, E; Kikuchi, S; Koike, Y; Kuwashiro, M; Matsuzaka, Y; Miyagi, T; Morizane, S; Murota, H; Nakahara, T; Ohata, C; Ohyama, B; Okada, E; Okazaki, F; Ota, M; Saito, K; Sasaki, N; Sugita, K; Takahashi, K; Tsuruta, N; Yamaguchi, K; Yanase, T; Yonekura, K; Yoshida, Y	1
Ellingsen, T; Horn, HC; Ruhoff, JT	1
Abramovits, W; Schlessinger, J	1
Acosta Felquer, ML; Galimberti, ML; LoGiudice, L; Mazzuoccolo, L; Rosa, J; Soriano, ER	1
Akasaka, E; Jin, K; Matsuzaki, Y; Nakano, H; Sawamura, D	1
Boehncke, WH; Gottlieb, AB; Kim, N; Krueger, GG; Merola, JF; Qureshi, A; Thaçi, D; Walsh, J	1
D'Amelio, R; Laganà, B; Picchianti-Diamanti, A; Rosado, MM; Scarsella, M	1
Bellia, G; Chimenti, S; Colombo, D; Di Nuzzo, S; Gargiulo, A; Griseta, V; Grossi, P; Marchesoni, A; Parodi, A; Simoni, L	1
Batat, E; Bitterman, H; Cohen, AD; Cohen, S; Comanesther, D; Feldhamer, I; Greenberg-Dotan, S; Shalom, G; Zisman, D	1
Lubrano, E; Marchesoni, A; Perrotta, FM	1
Bellia, G; Calzavara-Pinton, P; Chimenti, S; Colombo, D; Foti, R; Grossi, PA; Marchesoni, A; Ori, A; Zagni, E	1
Kim, JE; Ko, JY; Koh, WS; Oh, EH; Ro, YS; Shin, JM	1
Hino, R; Kabashima, K; Ogata, M; Sugita, K; Tokura, Y	1
Boiardi, L; Catanoso, M; Macchioni, P; Pigatto, P; Pipitone, N; Salvarani, C	1
Cutro, MS; D'Angelo, S; Ferrara, N; Leccese, P; Lubrano, E; Mennillo, GA; Olivieri, I	1
Bergler-Czop, B; Brzezińska-Wcisło, L; Lis-Święty, A	1
Antivalle, M; Atzeni, F; Boccassini, L; Salaffi, F; Sarzi-Puttini, P	1
Carsetti, R; D'Amelio, R; Diamanti, AP; Germano, V; Giorda, E; Laganà, B; Podestà, E; Rosado, M; Scarsella, M	1
Matuszewska, A; Misterska-Skóra, M; Wiland, P	1
Brzosko, I; Fliciński, J; Ostanek, L; Prajs, K; Przepiera-Bedzak, H	1
Boulinguez, S	1
Cerri, A; Colombo, L; Crespi, E; Gualandri, L; Mapelli, ET; Marconi, M; Menni, S	1
Arida, A; Fragiadaki, K; Giavri, E; Karanikolas, GN; Katsalira, A; Komninou, E; Koukli, EM; Lasithiotakis, I; Petrou, D; Sfikakis, PP; Vaiopoulos, G; Zacharioudaki, A	1
Engin Tezcan, M; Kaya, A; Mercan, R; Oner, Y; Ozturk, MA; Tufan, A	1
Di Minno, MN; Foglia, F; Iervolino, S; Lofrano, M; Peluso, R; Scarpa, R	1
Lubrano, E; Scarpa, R	1
Chinoy, H; Foulkes, AC; Griffiths, CE; Warren, RB	1
Burg, G; Forster, A; Heinzerling, L; Kamarashev, J; Lor, P; Nestle, FO	1
Emery, P; Fraser, A; Lawson, CA; Veale, DJ	1
Canapicchi, R; Ceravolo, R; Cosottini, M; Lazzarotti, G; Michelassi, MC; Murri, L	1
Gladman, DD	1
Dijkmans, BA; Emery, P; Fraser, AD; Gerards, AH; Karim, Z; Landewé, R; Steinfeld, SD; van Kuijk, AW; Veale, DJ; Wakefield, R; Westhovens, R	1
Hong, SB; Kim, NI	1
Kress, DW	1
Gordon, KB; Ruderman, EM	1
Cakmak, SK; Erdem, R; Gönül, M; Gül, U; Gündüz, H; Kiliç, A	1
Brzosko, M; Flicinski, J; Olewniczak, S	1
Dijkmans, BA; Finlay, AY; Griffiths, CE; Ho, VC; Johnston, A; Katsambas, A; Luger, TA; Mrowietz, U; Thestrup-Pedersen, K	1
Andonopoulos, AP; Antonopoulos, I; Daoussis, D; Liossis, SN	1
Dissemond, J; Grabbe, S	1
Girard, C; Guilhou, JJ	1
Boki, K; Ioannidou, P; Karafoulidou, A; Katsarou, O; Linardaki, G	1
McHugh, NJ; Soriano, ER	1
Stiefelhagen, P	1
Elston, CM; O'Toole, EA; Webber, NK	1
Alegre de Miguel, V; Martínez Casimiro, L; Sánchez Carazo, JL	1
Beutner, KR; Bhushan, R; Elmets, CA; Feldman, SR; Gordon, KB; Gottlieb, A; Koo, JY; Korman, NJ; Lebwohl, M; Leonardi, CL; Menter, A; Van Voorhees, AS	1
Bagot, M; Claudepierre, P	1
Katayama, I; Kimura, K; Nishioka, K; Yamamoto, T	1
Bartoli, E; Ferraccioli, G; Guerra, P; Rizzi, V	1
Färber, L; Mahrle, G; Schulze, HJ; Steigleder, GK; Weidinger, G	1
Coloni, L; De Sabbata, G; Mazzanti, G; Paladini, G	1
Bracci, M; Riccieri, V; Sili Scavalli, A; Spadaro, A; Taccari, E; Zoppini, A	1
Arenberger, P; Kemeny, L; Peter, RU; Ruzicka, T; Wagner, S	1
Adam, O; Peter, RU; Ruzicka, T; Wagner, SA	1
Hori, Y; Imayama, S; Yasumoto, S	1
Yocum, DE	1
Bräutigam, M; Färber, L; Jung, EG; Mahrle, G; Mischer, P; Schopf, R; Schulze, HJ; Weidinger, G	1
Antonelli, M; Antonelli, S; Ceralli, F; Lanciani, P; Minisola, G; Porzio, F; Porzio, V	1
Boiardi, L; Cantini, F; Macchioni, L; Niccoli, L; Olivieri, I; Padula, A; Portioli, I; Salvarani, C	1
Durez, P; Farber, CM; Heenen, M; Liesnard, C; Parent, D; Tourne, L; Van Vooren, JP	1
Scott, DG; Somerville, MF	1
Boiardi, L; Facchini, A; Macchioni, P; Maldini, MC; Meliconi, R; Pulsatelli, L; Ruggeri, R; Salvarani, C	1
Riccieri, V; Sensi, F; Sili Scavalli, A; Spadaro, A; Taccari, E; Zoppini, A	1
Battistel, B; Beltrandi, E; Boiardi, L; Casadei-Maldini, M; Cremonesi, T; Macchioni, P; Mancini, R; Salvarani, C	1
Akiba, H; Han, GW; Inoue, M; Iwatsuki, K; Kaneko, F; Kaneko, R; Matsui, T; Nishibu, A	1
Bouvenot, G; Chaudier, B; Chouc, PY; Fulpin, J; Jeandel, P; Sebahoun, G	1
Scarpa, R	1
Adami, JZ; Mallia, C; Mizzi, A; Pace, J	1
Antonio, R; Eugenio, R; Stefano, I	1
Mális, F; Raffayová, H; Rovenský, J	1
Blandino, A; Borgia, F; Cannavò, SP; Guarneri, B; Guarneri, F; Vaccaro, M	1
Bieber, T; Wenzel, J	1
Alberighi, OD; Bordin, G; Cantini, F; Cutolo, M; Davoli, C; Dovigo, L; Ferraccioli, G; Lovino, C; Macchioni, P; Marchesoni, A; Olivieri, I; Padula, A; Pasero, G; Salaffi, F; Salvarani, C	1
Belai-Beyene, N; Cazzola, M; Chèrié-Lignièré, EL; Fiorini, T; Panni, B; Sarzi-Puttini, P; Turiel, M	1
Beltrandi, E; Boiardi, L; Casadei Maldini, M; Lodi, L; Macchioni, P; Mancini, R; Portioli, I; Rossi, F; Salvarani, C	1
Kokelj, F; Lavaroni, G; Stinco, G	1
Beltrandi, E; Bisighini, G; Boiardi, L; Casadei Maldini, M; Lodi, L; Macchioni, P; Mancini, R; Portioli, I; Rossi, F; Salvarani, C	1
Buskila, D; Shoenfeld, Y; Sukenik, S	1
Goronzy, JJ; Jendro, M; Weyand, CM	1

Reviews

20 review(s) available for cyclosporine and Arthritis, Psoriatic

Article	Year
Efficacy of methotrexate in management of peripheral psoriatic arthritis - a systematic review. Danish medical journal, 2019, Volume: 66, Issue:10 Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Treatment Outcome; Tumor Necrosis Factor-alpha	2019
Efficacy and Safety of Systemic Treatments for Skin and Joint Manifestations in Patients With Psoriasis. Journal of drugs in dermatology : JDD, 2020, Mar-01, Volume: 19, Issue:3 Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Humans; Methotrexate; Psoriasis	2020
Diagnosing and treating psoriatic arthritis: an update. The British journal of dermatology, 2014, Volume: 170, Issue:4 Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Psoriatic; Biological Factors; Cyclosporine; Dermatologic Agents; Humans; Off-Label Use; Treatment Outcome; Tumor Necrosis Factor-alpha	2014
P-glycoprotein and drug resistance in systemic autoimmune diseases. International journal of molecular sciences, 2014, Mar-20, Volume: 15, Issue:3 Topics: Adrenal Cortex Hormones; Arthritis, Psoriatic; Arthritis, Rheumatoid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Drug Resistance; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Tacrolimus	2014
Sonozaki syndrome: case report and review of literature. Rheumatology international, 2012, Volume: 32, Issue:2 Topics: Arthritis, Psoriatic; Cyclosporine; Female; Humans; Middle Aged; Perfusion Imaging; Psoriasis; Sternoclavicular Joint; Syndrome	2012
Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs. Reumatismo, 2012, Jun-05, Volume: 64, Issue:2 Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Clinical Trials as Topic; Cyclosporine; Evidence-Based Medicine; Humans; Isoxazoles; Joints; Leflunomide; Methotrexate; Multicenter Studies as Topic; Nails; Skin; Sulfasalazine	2012
Psoriatic arthritis. Dermatologic therapy, 2004, Volume: 17, Issue:5 Topics: Adalimumab; Alefacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimalarials; Arthritis, Psoriatic; Azathioprine; Cyclosporine; Etanercept; Gold Sodium Thiomalate; Humans; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Recombinant Fusion Proteins; Sulfasalazine; Tumor Necrosis Factor Decoy Receptors	2004
Generalized pustular psoriasis following withdrawal of short-term cyclosporin therapy for psoriatic arthritis. Journal of the European Academy of Dermatology and Venereology : JEADV, 2005, Volume: 19, Issue:4 Topics: Adult; Arthritis, Psoriatic; Cyclosporine; Diagnosis, Differential; Humans; Immunosuppressive Agents; Leg; Male; Severity of Illness Index; Skin Diseases, Vesiculobullous	2005
The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach. Journal of the American Academy of Dermatology, 2006, Volume: 54, Issue:3 Suppl 2 Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Etanercept; Etretinate; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Keratolytic Agents; Methotrexate; Psoriasis; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha	2006
Update on the use of ciclosporin in immune-mediated dermatoses. The British journal of dermatology, 2006, Volume: 155 Suppl 2 Topics: Arthritis, Psoriatic; Cyclosporine; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Patient Selection; Psoriasis; Quality of Life; Skin Diseases; Skin Diseases, Papulosquamous	2006
[Biologics in the treatment of psoriasis]. MMW Fortschritte der Medizin, 2006, Sep-21, Volume: 148, Issue:38 Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Child; Child, Preschool; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Pregnancy; Psoriasis; PUVA Therapy; Receptors, Tumor Necrosis Factor; Time Factors	2006
[Psoriasis]. La Revue du praticien, 2006, Dec-15, Volume: 56, Issue:19 Topics: Acitretin; Adrenal Cortex Hormones; Adult; Age Factors; Arthritis, Psoriatic; Calcitriol; Child; Cyclosporine; Dermatologic Agents; Diagnosis, Differential; HIV Infections; Humans; Infant; Infant, Newborn; Keratolytic Agents; Methotrexate; Ointments; Phototherapy; Psoriasis; Skin; Time Factors; Vitamins	2006
Conventional therapy of psoriatic arthritis: evidence-based review. Reumatismo, 2007, Volume: 59 Suppl 1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Evidence-Based Medicine; Glucocorticoids; Humans; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Sulfasalazine; Treatment Outcome	2007
[Long-term control of psoriasis is necessary]. Actas dermo-sifiliograficas, 2008, Volume: 99 Suppl 1 Topics: Acitretin; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Biological Products; Combined Modality Therapy; Comorbidity; Cyclosporine; Cytokines; Dermatologic Agents; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Quality of Life; Recurrence	2008
[Psoriasis arthropathica]. Annales de dermatologie et de venereologie, 1993, Volume: 120, Issue:1 Topics: Adolescent; Adult; Arthritis, Psoriatic; Cyclosporine; Diagnosis, Differential; Female; Hand Dermatoses; Humans; Male; Sacroiliac Joint; Spondylitis, Ankylosing	1993
Cyclosporine, FK-506, rapamycin, and other immunomodulators. Rheumatic diseases clinics of North America, 1996, Volume: 22, Issue:1 Topics: Arthritis, Psoriatic; Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclosporine; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Polyenes; Sirolimus; Tacrolimus	1996
Therapy with cyclosporine in psoriatic arthritis. Seminars in arthritis and rheumatism, 1997, Volume: 27, Issue:1 Topics: Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Humans	1997
Psoriatic arthritis. Is something changing? Advances in experimental medicine and biology, 1999, Volume: 455 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Arthritis, Psoriatic; Cyclosporine; Gold; Humans; Methotrexate; Spondylitis, Ankylosing; Sulfasalazine	1999
Treatment with cyclosporin in patients with psoriatic arthritis: results of clinical assessment. International journal of clinical pharmacology research, 2000, Volume: 20, Issue:1-2 Topics: Adult; Arthritis, Psoriatic; Cholesterol; Creatinine; Cyclosporine; Dermatologic Agents; Drug Monitoring; Humans; Male; Middle Aged; Urea	2000
The possible role of prolactin in autoimmunity. American journal of reproductive immunology (New York, N.Y. : 1989), 1991, Volume: 26, Issue:3 Topics: Animals; Antibody Formation; Arthritis, Experimental; Arthritis, Psoriatic; Autoantibodies; Autoimmune Diseases; Autoimmunity; Bromocriptine; Cyclosporine; Drug Synergism; Female; Humans; Hyperprolactinemia; Immunity, Cellular; Immunocompetence; Male; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Pregnancy; Pregnancy Complications; Prolactin; Rats; Rheumatic Diseases; Uveitis	1991

Trials

13 trial(s) available for cyclosporine and Arthritis, Psoriatic

Article	Year
Combination therapy with ciclosporin and etanercept in patients with psoriatic arthritis. Annals of the rheumatic diseases, 2010, Volume: 69, Issue:5 Topics: Adult; Aged; Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Middle Aged; Pilot Projects; Receptors, Tumor Necrosis Factor; Treatment Outcome	2010
Etanercept plus ciclosporin versus etanercept plus methotrexate for maintaining clinical control over psoriatic arthritis: a randomised pilot study. Annals of the rheumatic diseases, 2011, Volume: 70, Issue:4 Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Male; Methotrexate; Middle Aged; Pilot Projects; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Treatment Outcome	2011
Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial. The Journal of rheumatology, 2011, Volume: 38, Issue:11 Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Disability Evaluation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Methotrexate; Middle Aged; Prospective Studies; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha	2011
A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis. Annals of the rheumatic diseases, 2005, Volume: 64, Issue:6 Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Quality of Life; Severity of Illness Index; Treatment Outcome	2005
Cyclosporin A increases somatomedin C insulin-like growth factor I levels in chronic rheumatic diseases. The Journal of rheumatology, 1995, Volume: 22, Issue:6 Topics: Arthritis, Psoriatic; Arthritis, Rheumatoid; Cyclosporine; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Osteocalcin	1995
Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement. Journal of the American Academy of Dermatology, 1995, Volume: 32, Issue:1 Topics: Administration, Cutaneous; Adult; Anthralin; Arthritis, Psoriatic; Blood Pressure; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Etretinate; Female; Follow-Up Studies; Germany; Humans; Male; Middle Aged; Nail Diseases; Psoriasis; Recurrence; Severity of Illness Index; Skin; Time Factors; Treatment Outcome	1995
Methotrexate and cyclosporin combined therapy in severe psoriatic arthritis. A pilot study. Acta dermato-venereologica. Supplementum, 1994, Volume: 186 Topics: Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged	1994
Anti-inflammatory efficacy of low-dose cyclosporin A in psoriatic arthritis. A prospective multicentre study. The British journal of dermatology, 1996, Volume: 135, Issue:5 Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Psoriatic; Blood Pressure; Creatinine; Cyclosporine; Female; Hand Strength; Humans; Male; Middle Aged; Pain Measurement; Prospective Studies; Time Factors; Treatment Outcome	1996
Neoral--new cyclosporin for old? British journal of rheumatology, 1997, Volume: 36, Issue:10 Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Behcet Syndrome; Biological Availability; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy; Emulsions; Humans; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone; Rheumatic Diseases; Severity of Illness Index; Surveys and Questionnaires	1997
Soluble interleukin-2 receptor and interleukin-6 levels: evaluation during cyclosporin A and methotrexate treatment in psoriatic arthritis. Clinical rheumatology, 1998, Volume: 17, Issue:1 Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Female; Humans; Interleukin-6; Male; Methotrexate; Middle Aged; Receptors, Interleukin-2; Solubility; Treatment Outcome	1998
Treatment with cyclosporin in patients with psoriatic arthritis: results of clinical assessment. International journal of clinical pharmacology research, 2000, Volume: 20, Issue:1-2 Topics: Adult; Arthritis, Psoriatic; Cholesterol; Creatinine; Cyclosporine; Dermatologic Agents; Drug Monitoring; Humans; Male; Middle Aged; Urea	2000
A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis. The Journal of rheumatology, 2001, Volume: 28, Issue:10 Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Female; Humans; Male; Middle Aged; Patient Compliance; Severity of Illness Index; Sulfasalazine; Treatment Outcome	2001
Long-term safety and efficacy of low-dose cyclosporin A in severe psoriatic arthritis. Rheumatology international, 2002, Volume: 21, Issue:6 Topics: Adult; Arthritis, Psoriatic; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome	2002

Other Studies

48 other study(ies) available for cyclosporine and Arthritis, Psoriatic

Article	Year
Survival rates of systemic interventions for psoriasis in the Western Japan Psoriasis Registry: A multicenter retrospective study. The Journal of dermatology, 2023, Volume: 50, Issue:6 Topics: Arthritis, Psoriatic; Biological Products; Cyclosporine; Humans; Japan; Psoriasis; Registries; Retrospective Studies; Survival Rate	2023
Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis. Annals of the rheumatic diseases, 2022, Volume: 81, Issue:1 Topics: Adalimumab; Adult; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Argentina; Arthritis, Psoriatic; Biological Products; Body Mass Index; Cyclosporine; Electronic Health Records; Etanercept; Female; Humans; Incidence; Infliximab; Male; Methotrexate; Middle Aged; Nail Diseases; Phototherapy; Psoriasis; Retrospective Studies; Risk Factors; Sex Factors; Ustekinumab; Young Adult	2022
Pyoderma gangrenosum triggered by switching from adalimumab to secukinumab. The Journal of dermatology, 2019, Volume: 46, Issue:3 Topics: Adalimumab; Administration, Oral; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Cyclosporine; Dermatologic Agents; Drug Substitution; Female; Humans; Middle Aged; Pyoderma Gangrenosum; Skin; Treatment Outcome	2019
Prevalence of past and reactivated viral infections and efficacy of cyclosporine A as monotherapy or in combination in patients with psoriatic arthritis--synergy study: a longitudinal observational study. BioMed research international, 2014, Volume: 2014 Topics: Adult; Antibodies, Viral; Arthritis, Psoriatic; Cyclosporine; Drug Synergism; Female; Humans; Infections; Longitudinal Studies; Male; Middle Aged; Seroepidemiologic Studies; Viruses	2014
Psoriatic arthritis treatment and the risk of herpes zoster. Annals of the rheumatic diseases, 2016, Volume: 75, Issue:1 Topics: Adalimumab; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Azathioprine; Cyclosporine; Drug Combinations; Drug Therapy, Combination; Etanercept; Female; Glucosamine; Herpes Zoster; Humans; Hydroxychloroquine; Incidence; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Tumor Necrosis Factor-alpha	2016
Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs. The Journal of rheumatology, 2016, Volume: 43, Issue:2 Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Humans; Immunologic Factors; Male; Methotrexate; Middle Aged; Prognosis; Prospective Studies; Remission Induction; Severity of Illness Index; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha	2016
Efficacy of cyclosporine A as monotherapy in patients with psoriatic arthritis: a subgroup analysis of the SYNERGY Study. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2017, Volume: 152, Issue:3 Topics: Arthritis, Psoriatic; Cross-Sectional Studies; Cyclosporine; Female; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Middle Aged; Treatment Outcome	2017
Clinical experience of cyclosporin treatment in patients with psoriasis and psoriatic arthritis. The Journal of dermatology, 2018, Volume: 45, Issue:3 Topics: Adult; Arthritis, Psoriatic; Cyclosporine; Female; Humans; Male; Middle Aged; Prospective Studies; Psoriasis; Severity of Illness Index; Treatment Outcome; Young Adult	2018
Fluctuation of circulating plasmacytoid dendritic cells in a patient with psoriatic arthritis. Journal of the European Academy of Dermatology and Venereology : JEADV, 2008, Volume: 22, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Psoriatic; Cyclosporine; Dendritic Cells; Humans; Immunophenotyping; Male; Methotrexate	2008
Multidisciplinary focus on cyclosporin A. The Journal of rheumatology. Supplement, 2009, Volume: 83 Topics: Arthritis, Psoriatic; Cyclosporine; Humans; Immunosuppressive Agents	2009
Reversion of resistance to immunosuppressive agents in three patients with psoriatic arthritis by cyclosporine A: modulation of P-glycoprotein function. Clinical immunology (Orlando, Fla.), 2011, Volume: 138, Issue:1 Topics: Adult; Arthritis, Psoriatic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Sedimentation; C-Reactive Protein; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; Joints; Male; Methotrexate; Middle Aged; Rhodamine 123; Sulfasalazine; T-Lymphocytes; Treatment Outcome; Verapamil	2011
[Active psoriatic arthritis during pregnancy: challenges and limitations of pharmacotherapy]. Annales Academiae Medicae Stetinensis, 2010, Volume: 56 Suppl 1 Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Contraindications; Cyclosporine; Female; Humans; Isoxazoles; Leflunomide; Methotrexate; Prednisolone; Prednisone; Pregnancy; Pregnancy Complications; Sulfasalazine	2010
[Adverse effects of cyclosporin a observed in rheumatoid arthritis and psoriatic arthritis]. Annales Academiae Medicae Stetinensis, 2010, Volume: 56 Suppl 1 Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Creatinine; Cyclosporine; Diarrhea; Dose-Response Relationship, Drug; Drug Therapy, Combination; Feeding and Eating Disorders; Female; Follow-Up Studies; Hirsutism; Humans; Hypertension; Male; Methotrexate; Middle Aged; Peripheral Nervous System Diseases; Tremor	2010
[News on psoriasis from the 2010 Dermatology Days in Paris]. Annales de dermatologie et de venereologie, 2011, Volume: 138, Issue:5 Suppl 1 Topics: Acitretin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Cyclosporine; Dermatologic Agents; Dermatology; Drug Therapy, Combination; Etanercept; Evidence-Based Medicine; Humans; Immunoglobulin G; Methotrexate; Practice Guidelines as Topic; Psoriasis; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Treatment Outcome; Ustekinumab	2011
Superimposed linear psoriasis: low effectiveness of biologic therapy. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2011, Volume: 146, Issue:4 Topics: Acitretin; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Biological Therapy; Cyclosporine; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Loss of Heterozygosity; Male; Methotrexate; Psoriasis; Receptors, Tumor Necrosis Factor	2011
Aortitis in a patient with psoriatic arthritis. Modern rheumatology, 2012, Volume: 22, Issue:5 Topics: Antibodies, Monoclonal; Antirheumatic Agents; Aorta, Thoracic; Aortitis; Arthritis, Psoriatic; Cyclosporine; Drug Resistance; Drug Substitution; Etanercept; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Receptors, Tumor Necrosis Factor; Remission Induction; Treatment Outcome; Young Adult	2012
Clinical manifestation of selective IgA deficiency evidence after anti-TNF-α treatment in a psoriatic arthritis patient: case report. Reumatismo, 2012, Mar-19, Volume: 64, Issue:1 Topics: Adalimumab; Adult; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Disease Susceptibility; Folliculitis; Herpes Labialis; Humans; IgA Deficiency; Immunocompromised Host; Immunosuppressive Agents; Irritable Bowel Syndrome; Male; Methylprednisolone; Milk Hypersensitivity; Mycoses; Stomatitis; Tumor Necrosis Factor-alpha	2012
Unmasking of axial spondyloarthritis and oligoarthritis following discontinuation of tumour necrosis factor inhibitor therapy for psoriasis. The Journal of dermatological treatment, 2014, Volume: 25, Issue:1 Topics: Adalimumab; Adult; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Cyclosporine; Drug Substitution; Humans; Immunosuppressive Agents; Knee Injuries; Male; Methotrexate; Osteoarthritis, Knee; Psoriasis; Spondylarthritis; Tumor Necrosis Factor-alpha; Ustekinumab; Withholding Treatment	2014
Generalised pustular psoriasis induced by cyclosporin a withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept. Dermatology (Basel, Switzerland), 2002, Volume: 205, Issue:2 Topics: Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Middle Aged; Psoriasis; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha	2002
Cyclosporin treatment in psoriatic arthritis: a cause of severe leg pain. Annals of the rheumatic diseases, 2003, Volume: 62, Issue:5 Topics: Adolescent; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Female; Humans; Leg; Pain	2003
Cyclosporine-related posterior reversible encephalopathy syndrome (PRES) in non-transplant patient: a case report and literature review. European journal of neurology, 2003, Volume: 10, Issue:4 Topics: Arthritis, Psoriatic; Brain Diseases; Cerebral Cortex; Cyclosporine; Enzyme Inhibitors; Female; Humans; Hypertensive Encephalopathy; Magnetic Resonance Imaging; Mental Disorders; Middle Aged; Speech Disorders; Tomography, X-Ray Computed	2003
Etanercept therapy improves symptoms and allows tapering of other medications in children and adolescents with moderate to severe psoriasis. Journal of the American Academy of Dermatology, 2006, Volume: 54, Issue:3 Suppl 2 Topics: Adolescent; Arthritis, Psoriatic; Child; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Psoriasis; Treatment Outcome	2006
Treatment of psoriatic arthritis with etanercept, methotrexate, and cyclosporin A. Clinical therapeutics, 2006, Volume: 28, Issue:2 Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Infusions, Parenteral; Male; Methotrexate; Receptors, Tumor Necrosis Factor; Suppositories	2006
Multiple haemangiomas in a psoriatic arthritis patient treated with cyclosporine. Acta dermato-venereologica, 2006, Volume: 86, Issue:3 Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Diagnosis, Differential; Forearm; Hemangioma; Humans; Male; Skin Neoplasms; Thigh	2006
Increased expression of CD154 (CD40L) on stimulated T-cells from patients with psoriatic arthritis. Rheumatology (Oxford, England), 2007, Volume: 46, Issue:2 Topics: Adult; Aged; Arthritis, Psoriatic; Arthritis, Rheumatoid; CD40 Ligand; CD8-Positive T-Lymphocytes; Cells, Cultured; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lymphocyte Activation; Male; Middle Aged; T-Lymphocytes	2007
Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection. The Journal of rheumatology, 2007, Volume: 34, Issue:6 Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Etanercept; Hepatitis C; HIV Infections; Humans; Immunoglobulin G; Male; Methotrexate; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha	2007
[Therapeutic strategies against psoriasis. Skin to hide -- and how do you free your patients from it]. MMW Fortschritte der Medizin, 2007, Sep-06, Volume: 149, Issue:35-36 Topics: Adrenal Cortex Hormones; Anthralin; Arthritis, Psoriatic; Biological Products; Cyclosporine; Dermatologic Agents; Female; Fumarates; Humans; Male; Methotrexate; Phototherapy; Psoriasis; PUVA Therapy; Retinoids; Sex Factors	2007
Generalized pustular psoriasis and cryptogenic organizing pneumonia. The British journal of dermatology, 2008, Volume: 158, Issue:4 Topics: Acitretin; Adult; Arthritis, Psoriatic; Cryptogenic Organizing Pneumonia; Cyclosporine; Dermatologic Agents; Etanercept; Fatal Outcome; Female; Humans; Immunoglobulin G; Protein C Inhibitor; Psoriasis; Receptors, Tumor Necrosis Factor	2008
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. Journal of the American Academy of Dermatology, 2008, Volume: 58, Issue:5 Topics: Acitretin; Alefacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Biological Products; Cardiovascular Diseases; Cyclosporine; Depression; Etanercept; Humans; Immunoglobulin G; Interleukin-12; Interleukin-23; Lymphoma; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; PUVA Therapy; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Smoking; Tumor Necrosis Factor-alpha	2008
[Psoriatic arthritis]. Annales de dermatologie et de venereologie, 2008, Volume: 135 Suppl 4 Topics: Arthritis, Psoriatic; Cyclosporine; Diagnosis, Differential; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Psoriasis	2008
Successful treatment of severe arthralgia associated with palmoplantar pustulosis with low-dose oral cyclosporine A. The Journal of dermatology, 1995, Volume: 22, Issue:7 Topics: Administration, Oral; Adult; Arthralgia; Arthritis, Psoriatic; Cyclosporine; Female; Humans; Immunosuppressive Agents; Middle Aged; Psoriasis	1995
Short-term "cyclosporin A" therapy for psoriatic arthritis. Acta dermato-venereologica. Supplementum, 1994, Volume: 186 Topics: Adult; Arthritis, Psoriatic; Cyclosporine; Female; Humans; Male; Middle Aged	1994
Therapeutic efficacy of oral low-dose cyclosporin A in severe psoriatic arthritis. Dermatology (Basel, Switzerland), 1993, Volume: 186, Issue:1 Topics: Administration, Oral; Adult; Aged; Arthritis, Psoriatic; Cyclosporine; Follow-Up Studies; Humans; Male; Middle Aged; Severity of Illness Index; Treatment Outcome	1993
Increased serum level of interleukin-6 in patients with psoriatic arthritis and thrombocytosis. The Journal of dermatology, 1995, Volume: 22, Issue:10 Topics: Adult; Anti-Inflammatory Agents; Arthritis, Psoriatic; B-Lymphocytes; Blood Platelets; C-Reactive Protein; Cyclosporine; Fatigue; Female; Fever; Humans; Immunosuppressive Agents; Interleukin-6; Lymphocyte Activation; Male; Platelet Count; Prednisolone; T-Lymphocytes; Thrombocytosis	1995
Cyclosporin A in the long-term treatment of psoriatic arthritis. British journal of rheumatology, 1996, Volume: 35, Issue:12 Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Female; Humans; Male; Middle Aged; Time Factors	1996
Alleviation of HIV-associated psoriasis and psoriatic arthritis with cyclosporine. Journal of the American Academy of Dermatology, 1997, Volume: 37, Issue:3 Pt 1 Topics: Adult; Arthritis, Psoriatic; Cyclosporine; HIV Infections; Humans; Male; Psoriasis	1997
Serum chemokines in patients with psoriatic arthritis treated with cyclosporin A. The Journal of rheumatology, 1998, Volume: 25, Issue:2 Topics: Adult; Aged; Arthritis, Psoriatic; Chemokine CCL2; Chemokine CCL4; Chemokine CCL5; Chemokines; Cyclosporine; Female; Humans; Interleukin-8; Macrophage Inflammatory Proteins; Male; Middle Aged; Time Factors	1998
The relationship between serum-soluble interleukin-2 receptor and radiological evolution in psoriatic arthritis patients treated with cyclosporin-A. Rheumatology international, 1998, Volume: 18, Issue:1 Topics: Administration, Oral; Arthritis, Psoriatic; Biomarkers; Cyclosporine; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Finger Joint; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Prognosis; Prospective Studies; Radiography; Receptors, Interleukin-2; Tarsal Joints	1998
Overexpression of monocyte-derived cytokines in active psoriasis: a relation to coexistent arthropathy. Journal of dermatological science, 1999, Volume: 21, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Arthritis, Psoriatic; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Female; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukins; Male; Middle Aged; Monocytes; Reverse Transcriptase Polymerase Chain Reaction; Severity of Illness Index	1999
[Hairy cell leukemia during treatment of psoriatic polyarthritis with methotrexate]. Presse medicale (Paris, France : 1983), 1999, Sep-18, Volume: 28, Issue:27 Topics: Arthritis, Psoriatic; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia, Hairy Cell; Male; Methotrexate; Middle Aged	1999
Toxic epidermal necrolysis in a patient with psoriatic arthritis. Advances in experimental medicine and biology, 1999, Volume: 455 Topics: Adrenal Cortex Hormones; Arthritis, Psoriatic; Cyclosporine; Erythema; Female; Humans; Immunosuppressive Agents; Middle Aged; Plasmapheresis; Stevens-Johnson Syndrome	1999
Echographic test and cyclosporin therapy in psoriatic arthritis. Journal of the European Academy of Dermatology and Venereology : JEADV, 2000, Volume: 14, Issue:3 Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Female; Humans; Male; Ultrasonography	2000
Successful treatment of pustulotic arthro-osteitis (Sonozaki syndrome) with systemic cyclosporin. Clinical and experimental dermatology, 2001, Volume: 26, Issue:1 Topics: Arthritis, Psoriatic; Cyclosporine; Humans; Immunosuppressive Agents; Male; Middle Aged; Treatment Outcome	2001
Cyclosporin A in treatment of refractory adult polymyositis/dermatomyositis. The Journal of rheumatology, 2001, Volume: 28, Issue:9 Topics: Adult; Aged; Arthritis, Psoriatic; Behcet Syndrome; Cyclosporine; Dermatomyositis; Female; Follow-Up Studies; Humans; Muscular Diseases; Polymyositis; Risk Assessment	2001
Immunologic effects in patients with psoriatic arthritis treated with cyclosporine A. The Journal of rheumatology, 1992, Volume: 19, Issue:12 Topics: Antigens, CD; Antigens, CD20; Antigens, Differentiation, B-Lymphocyte; Antigens, Differentiation, T-Lymphocyte; Arthritis, Psoriatic; CD3 Complex; CD4-CD8 Ratio; CD56 Antigen; Cyclosporine; HLA-DR Antigens; Humans; Killer Cells, Natural; Leukocytes, Mononuclear; Lymphocyte Activation; Phenotype; Prospective Studies; Receptors, IgG; T-Lymphocytes	1992
Psoriatic arthritis treated with cyclosporin A. Allergie et immunologie, 1992, Volume: 24, Issue:10 Topics: Adult; Aged; Arthritis, Psoriatic; Cyclosporine; Drug Evaluation; Female; Humans; Male; Middle Aged	1992
Low dose cyclosporine A in psoriatic arthritis: relation between soluble interleukin 2 receptors and response to therapy. The Journal of rheumatology, 1992, Volume: 19, Issue:1 Topics: Arthritis, Psoriatic; Cyclosporine; Dose-Response Relationship, Drug; Humans; Joints; Pain; Receptors, Interleukin-2; Solubility	1992
Soluble HLA-DR molecules in patients with HLA class II versus class I associated disorders. Autoimmunity, 1991, Volume: 8, Issue:4 Topics: Arthritis, Psoriatic; Arthritis, Rheumatoid; Autoimmune Diseases; beta 2-Microglobulin; Blood Sedimentation; Cyclosporine; HLA-DR Antigens; Humans; Interferon-gamma; Longitudinal Studies; Lupus Erythematosus, Systemic; Lyme Disease; Scleroderma, Localized; Spondylitis; Vasculitis	1991